The United States on Wednesday indicated it no longer expects Syrian President Bashar Assad’s regime to fully disclose its chemical-warfare assets this week, an expectation established several days ago under a U.S.-Russian plan for Damascus to eventually relinquish the stocks, the Los Angeles Times reported.
“Our goal is to see forward momentum,” but not necessarily a full declaration, before Sunday, U.S. State Department spokeswoman Marie Harf said. “We’ve never said it was a hard and fast deadline,” the spokeswoman added.
Several days ago, Secretary of State John Kerry said he and Russia’s top diplomat had decided Damascus would have one week to provide “a comprehensive listing” of its chemical-weapon assets. Washington would permit “no games, no room for avoidance, or anything less than full compliance,” he said then.
A senior Russian diplomat on Wednesday said Damascus “within a week” would send a chemical-arms declaration to the Organization for the Prohibition of Chemical Weapons, ITAR-Tass reported. The Russian state-owned news agency did not specify whether the information would amount to a complete disclosure.
The 41-nation OPCW Executive Council is set on Friday to begin discussing formal procedures for eliminating the Assad government’s chemical arsenal, the Wall Street Journal reported. One expert said the council is likely to adopt a U.S.-Russian timeline calling for full destruction of the stockpile by the middle of next year, though the multilateral body is not obligated to do so.
Separately, Moscow intends by Friday to circulate Syrian-government indications that Assad’s opponents have carried out chemical strikes, Russian Deputy Foreign Minister Mikhail Bogdanov said in Thursday remarks quoted by ITAR-Tass.
In a Wednesday interview with Fox News, Assad challenged Washington to foot the bill for destroying the arms and “take the responsibility of bringing toxic materials to the United States,” Reuters reported. He also reaffirmed denials that his government had used its chemical arms in the Syrian civil war, now in its third year.
What We're Following See More »
Senate Judiciary Committee Chairman Chuck Grassley (R-IA) said Monday he'd now be willing to hold a hearing on Supreme Court nominee Merrick Garland in a lame-duck session of Congress. While he said he wouldn't push for it, he said if "Hillary Clinton wins the White House, and a majority of senators convinced him to do so," he would soften his previous opposition.
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.